Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -165,867 | -292,305 | -237,113 | -166,093 | -118,548 |
| Depreciation Amortization | -2,977 | -11,768 | -2,299 | 1,452 | 716 |
| Income taxes - deferred | N/A | -853 | -769 | -48 | 17 |
| Accounts receivable | -5,000 | N/A | N/A | N/A | N/A |
| Other Working Capital | -16,540 | 5,864 | 13,252 | 16,605 | 7,844 |
| Other Operating Activity | 19,524 | 91,240 | 63,178 | -6,009 | 23,146 |
| Operating Cash Flow | $-170,860 | $-207,822 | $-163,751 | $-154,093 | $-86,825 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 176,717 | -43,875 | -111,632 | 2,312 | -284,074 |
| PPE Investments | -156 | -583 | -2,548 | -6,107 | -758 |
| Other Investing Activity | 0 | 0 | 0 | -14,320 | 0 |
| Investing Cash Flow | $176,561 | $-44,458 | $-114,180 | $-18,115 | $-284,832 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 349 | 237,303 | 261,043 | 179,667 | 327,787 |
| Other Financing Activity | -241 | 0 | 0 | -1,146 | 32,652 |
| Financing Cash Flow | $108 | $237,303 | $261,043 | $178,521 | $360,439 |
| Beginning Cash Position | 30,719 | 45,696 | 62,584 | 56,271 | 67,489 |
| End Cash Position | 36,528 | 30,719 | 45,696 | 62,584 | 56,271 |
| Net Cash Flow | $5,809 | $-14,977 | $-16,888 | $6,313 | $-11,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -170,860 | -207,822 | -163,751 | -154,093 | -86,825 |
| Capital Expenditure | -221 | -583 | -2,548 | -6,107 | -758 |
| Free Cash Flow | -171,081 | -208,405 | -166,299 | -160,200 | -87,583 |